Stay updated on Zimura for AMD: Phase 3 Clinical Trial
Sign up to get notified when there's something new on the Zimura for AMD: Phase 3 Clinical Trial page.

Latest updates to the Zimura for AMD: Phase 3 Clinical Trial page
- Check3 days agoChange DetectedA new publication entry was added to the Publications section: Khanani AM, Danzig CJ, Heier JS, Jaffe GJ, Kaiser PK, Lally DR, Patel SS, Vajzovic L, Weng CY, Patel H, Clark J, Desai D, Luo D, Henry E, Holz FG; GATHER2 trial investigators. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 2-year efficacy and safety results from the GATHER2 phase 3 trial. Ophthalmology. 2025; Online ahead of print. This adds an additional reference related to the study drug.SummaryDifference0.0%

- Check10 days agoChange DetectedLocations were updated to include numerous new sites across the United States and other countries, while many prior locations were removed. This expands and reallocates where participants can enroll.SummaryDifference1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe Publications section description was updated to say publications are automatically filled in from PubMed. The page revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check39 days agoChange DetectedRemoval of the government funding status notice from the page; this banner is informational and does not alter study details, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedOnly minor metadata updates such as timestamps and location counts were made, and core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check68 days agoChange DetectedThe changes shift the page toward a stricter data-sharing stance by removing specific IPD sharing details and study documents, while adding general dates and a reiteration of the policy link. This reduces accessibility of study data and documents.SummaryDifference5%

Stay in the know with updates to Zimura for AMD: Phase 3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zimura for AMD: Phase 3 Clinical Trial page.